Clinical Trials
13 trialsNCT05349331 2026-01-15
WATCH
Sun Yat-sen University
Phase 2 Completed
NCT03813953 2024-05-22
LIVER 3
University of Edinburgh
Phase NA Completed
NCT03801915 2023-03-21
Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal Cancers
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT05471674 2023-02-01
Neoadjuvant Anti-PD1 in HCC
The University of Hong Kong
Phase 2 Completed
NCT02954913 2021-02-12
RESECT
Hamilton Health Sciences Corporation
Phase NA Completed
NCT01938729 2020-09-11
Hepatic Arterial Infusion With Floxuridine and Dexamethasone in Combination With Gemcitabine as Adjuvant Treatment After Resection of Intrahepatic Cholangiocarcinoma
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT01952353 2019-03-07
Preoperative Transarterial Chemoembolization for Resectable HCC With Portal Venous Invasion
Sun Yat-sen University
Phase 4 Completed
NCT01409499 2018-09-11
2011PTAHCC
Sun Yat-sen University
Phase 4 Completed
NCT03131778 2017-05-01
The Inflammatory Response to Stress and Angiogenesis in Liver Resection
University Hospital, Ghent
Phase NA Completed
NCT02728219 2016-04-05
HCCTACEAFP
Eastern Hepatobiliary Surgery Hospital
Phase NA Completed
NCT02031952 2014-01-09
Hepatectomy Versus Hepatectomy With Lymphadenectomy in Hepatocellular Carcinoma
Sun Yat-sen University
Phase NA Completed
NCT00153998 2009-02-27
Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM)
Technische Universität Dresden
Phase 2 Completed
NCT00652587 2008-04-03
Hepatectomy With or Without Transcatheter Arterial Chemoembolization for Stage IIIA Hepatocellular Carcinoma
Sun Yat-sen University
Phase 3 Completed